A year after the US Food and Drug Administration (FDA) opened the door to clinical use of lysergic acid diethylamide (LSD), US-based MindMed has launched phase 3 trials in the United States and ...

Now he’s back with “LSD.” “LSD” is not officially out yet; it came out last week through this link that makes you follow him on Spotify. It’s likely a Heavy Metal outtake, twinkly like ...

Community clinic names new chief health officer UC Davis testing shows benefit from rearranged LSD molecule UC Davis testing shows benefit from rearranged LSD molecule Sacramento Kings' startup ...

KWONG: Yeah, so given this, researchers looked at a molecule that has a similar structure to LSD and just removed the trip, which, in theory, would make this kind of treatment accessible to more ...

LSD has always been a source of fascination for Olson because of its outstanding ability to form and strengthen neural pathways. “We have consistently found that LSD is among the best ...

"No one really wants to give a hallucinogenic molecule like LSD to a patient with schizophrenia," said Olson, who is also co-founder and chief innovation officer of Delix Therapeutics, a company ...

Prior studies have suggested that certain parts of the LSD molecule are responsible for triggering hallucinations – specifically, a small chemical group that forms a key interaction with brain ...

To design the molecule (+)-JRT the researchers flipped the position of just two atoms in LSD’s molecular structure. The chemical flip reduced JRT’s hallucinogenic potential while maintaining ...